Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

CBIO stock price forecast

How will CBIO stock perform in 2026 and 2030?

This page primarily displays the projected price range for CBIO stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of CBIO, the development trends of Crescent Biopharma, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for CBIO. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Crescent Biopharma, Inc.'s financial performance and industry trends to provide short-term price predictions for CBIO stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year CBIO stock price forecast

Price target:
13.14 USD
+46.98%
Based on 1-year price forecasts from 39 analysts, the highest estimate is 16.86 USD, while the lowest estimate is 7.91 USD.

Analyst rating for CBIO

Based on ratings from 37 analysts over the past three months, the overall consensus is Hold.

Strong buy
5
Buy
17
Hold
4
Sell
11
Strong sell
0

Tez-tez beriladigan savollar

How has CBIO's EPS performed recently?

CBIO's EPS is projected to reach -- USD next quarter. Explore more Crescent Biopharma, Inc. financial data and stay up to date on the company's latest developments on the CBIO stock details page.

What is the revenue forecast for CBIO next quarter?

Crescent Biopharma, Inc.'s revenue is projected to reach 10.00M USD USD in the next quarter. You can view Crescent Biopharma, Inc.'s revenue and earnings on the CBIO stock details page.

What is the price target for CBIO?

Based on analyst estimates, the most likely target price for CBIO over the next 12 months is 13.14 USD, with a projected high of 16.86 USD and a projected low of 7.91 USD. To track whether this target is reached within the next year, you can view the CBIO stock price chart on the CBIO stock details page to check the current CBIO stock price, or follow the latest developments related to CBIO on the CBIO Stock News page.

What is the analyst rating for CBIO?

We collected ratings from 37 analysts who have evaluated CBIO stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of CBIO stock in 2030?

Based on price forecasts and analyses of Crescent Biopharma, Inc. from Wall Street analysts and major investment banks, CBIO is projected to trade between 17.88 USD and 89.40 USD in 2030.

CBIO stock chart

CBIO stock details

CBIO aksiya narxining o'zgarishi

Oxirgi savdo kunida, CBIO aksiya 8.94 USD narxda yopildi, kun uchun narx o'zgarishi -3.14%.

Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
NASDAQ/
CBIO stock price forecast